128 related articles for article (PubMed ID: 10085408)
1. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ
Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408
[TBL] [Abstract][Full Text] [Related]
2. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
[TBL] [Abstract][Full Text] [Related]
4. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
[TBL] [Abstract][Full Text] [Related]
5. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
6. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
[TBL] [Abstract][Full Text] [Related]
7. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas.
Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Plendl H; Metzke S; Joos S; Zucca E; Weber-Matthiesen K; Roggero E; Grote W; Schlegelberger B
Ann Oncol; 1998 May; 9(5):519-26. PubMed ID: 9653493
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.
Stamatopoulos K; Kosmas C; Belessi C; Kyriazopoulos P; Papadaki T; Anagnostou D; Loukopoulos D
Br J Haematol; 1999 Apr; 105(1):190-7. PubMed ID: 10233383
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma.
Luthra R; Hai S; Pugh WC
Diagn Mol Pathol; 1995 Mar; 4(1):4-7. PubMed ID: 7735555
[TBL] [Abstract][Full Text] [Related]
11. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Leukemia; 1993 Feb; 7(2):241-5. PubMed ID: 8426477
[TBL] [Abstract][Full Text] [Related]
15. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
16. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
[TBL] [Abstract][Full Text] [Related]
17. Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).
Luthra R; Sarris AH; Hai S; Paladugu AV; Romaguera JE; Cabanillas FF; Medeiros LJ
Am J Clin Pathol; 1999 Oct; 112(4):524-30. PubMed ID: 10510675
[TBL] [Abstract][Full Text] [Related]
18. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.
Ott G; Kalla J; Ott MM; Schryen B; Katzenberger T; Müller JG; Müller-Hermelink HK
Blood; 1997 Feb; 89(4):1421-9. PubMed ID: 9028966
[TBL] [Abstract][Full Text] [Related]
19. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues.
Lim LC; Segal GH; Wittwer CT
Am J Clin Pathol; 1995 Dec; 104(6):689-95. PubMed ID: 8526214
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
